Pricing Log in Create free account

Gain Therapeutics, Inc. (GANX) vs Sangamo Therapeutics, Inc. (SGMOQ)

Gain Therapeutics, Inc. and Sangamo Therapeutics, Inc. are both Biotechnology companies. Gain Therapeutics, Inc. and Sangamo Therapeutics, Inc. are of similar size ($41.9M and $41.9M). Gain Therapeutics, Inc. grew revenue faster over the last twelve months: 18.4% against −45.8%. Gain Therapeutics, Inc. has the higher net margin (0.00% vs −356.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Gain Therapeutics, Inc. leads on 10 and Sangamo Therapeutics, Inc. on 6.

Valuation

Metric GANX SGMOQ Biotechnology median
P/E n/m n/m 10.60
P/S 219.56 1.24 9.40
P/B 3.80 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 154.32 1.24 9.02
Earnings yield (50.00%) (345.45%) (32.88%)
Free cash flow yield (44.25%) (211.06%) (23.13%)

Profitability

Metric GANX SGMOQ Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% (357.55%) 0.00%
Net margin 0.00% (356.89%) 0.00%
Free cash flow margin 0.00% (261.76%) 0.00%
Return on equity (268.30%) 1,755.72% (51.96%)
Return on assets (159.22%) (168.79%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GANX SGMOQ Biotechnology median
Revenue growth (TTM) 18.36% (45.80%) 6.76%
EPS growth (last fiscal year) 31.46% 10.20% 29.88%
Revenue growth, 5-year CAGR 21.79% (19.66%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GANX SGMOQ Biotechnology median
Debt to equity 0.03 0.00 0.00
Current ratio 4.36 0.70 4.97
Net debt to EBITDA 1.10 0.18 1.01

Dividend

Metric GANX SGMOQ Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GANX SGMOQ Biotechnology median
Market cap 41.91m 41.89m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack